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Identiﬁcation of protein translation start sites is largely a bioinformatics exercise, with relatively few
conﬁrmed by N-terminal sequencing. Translation start site determination is critical for deﬁning both
the protein sequence and the upstream DNA which may contain regulatory motifs. It is
demonstrated here that translation start sites can be determined during routine protein
identiﬁcation, using MALDI-MS and MS/MS data to select the correct N-terminal sequence from a
list of alternatives generated in silico. Applying the method to 13 proteins from Mycobacterium
tuberculosis,11predictedtranslationalstartsiteswereconﬁrmed,andtworeassigned.Theauthors
suggest that these data (be they conﬁrmation or reassignments) are important for the annotation of
both this genome and those of organisms with related genes. It was also shown that N-acetylation,
reported to be rare in prokaryotes, was present in three of the 13 proteins (23%), suggesting
that in the mycobacteria this modiﬁcation may be common, and an important regulator of
protein function, although more proteins need to be analysed. This method can be performed with
little or no additional experimental work during proteomics investigations.
INTRODUCTION
The sequencing of complete genomes allows every poten-
tially encoded protein to be identiﬁed. In prokaryotes, gene
ﬁnding using a combination of bioinformatic factors
(homology with other predicted proteins, third base
preference, etc.) is quite efﬁcient, and is generally achieved
by a combination of automated and manual curation
(Brent, 2005). However, the ﬁnal proof that a gene is
expressed as a protein can only be provided by experimental
protein analysis. Proteomic approaches have been used to
conﬁrm many predicted genes, as well as to identify genes
not easily found bioinformatically (Jungblut et al., 2001).
However, there is one aspect of the annotation that is
difﬁcult to predict and usually remains experimentally
untested: the translational start site (TSS).
Determining the TSS accurately is important, not only
because this deﬁnes the amino acid sequence of the protein
(as the stop codon is unambiguous), but also because this
deﬁnes the upstream region in the DNA. Genome-wide and
focused studies of promoter structure and regulatory motifs
depend on the intergenic regions deﬁned by the gene-
ﬁnding process (Edwards et al., 2005; Salgado et al., 2000).
The TSS assignment therefore affects the analysis of both
protein function and transcriptional regulation.
Traditionally, TSS identiﬁcation has been achieved using N-
terminal sequencing by Edman degradation (Edman, 1950).
This is often technically demanding, and requires large
(picomole) quantities of protein. Furthermore, some
proteins are blocked through N-terminal modiﬁcations
and cannot be sequenced. Proteomic approaches using
sensitive MS methods (Jungblut et al., 1999, 2000) have
revolutionized protein analysis because of the speed and
sensitivity of the technology, but are not used to identify
TSSs.
In this paper we apply rapid proteomic analysis methods to
the issue of identifying TSSs. As the same data generated for
protein identiﬁcation could simultaneously identify protein
starts, this is therefore a highly efﬁcient approach. We were
able to conﬁrm the predicted N termini of 11 proteins, and
to correct the predictions for two proteins from
Mycobacterium tuberculosis. We also demonstrated that in
contrast to the predicted situation in Escherichia coli, a high
proportion (23%) of the proteins showed N-terminal
acetylation.
Sample outputs of the programs AlternaStart.pl, proteogest and
ParseProteogest.pl are available as supplementary data with the
online version of this paper.
Abbreviations: 2-DE, 2D gel electrophoresis; fMet, formyl-methionine;
TSS, translational start site.
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Alternative start codon identiﬁcation. The following strategy
was used to generate alternative TSSs for each predicted gene in the
M. tuberculosis genome. Each protein coding sequence in the EMBL
entry [identiﬁed as a coding sequence (CDS) in the feature table]
was considered in turn. The region upstream of the gene was
scanned until an in-frame stop codon was identiﬁed; by deﬁnition,
alternative start codons for the gene cannot be found upstream of
such a stop codon. The in-frame codons downstream of this stop
codon were scanned, and the position and triplet code of each alter-
native start codon (ATG, GTG or TTG) were recorded (these are the
‘m’ start codons in Fig. 1). Similarly, in-frame codons downstream
of the original start codon (p0) were scanned for alternative start
codons. Only the ﬁrst two downstream alternative start codons were
considered at this stage (these are the p1 and p2 codons in Fig. 1).
For each predicted alternative start, the new protein sequence
encoded was generated. Thus, from the 3999 coding sequences listed
in AL123456.2, 15199 alternative start protein sequences were iden-
tiﬁed. This procedure was performed using a Perl program
(AlternaStart.pl). The output of program AlternaStart.pl is available
as Supplementary Table S1. All sequences in this manuscript were
derived from the M. tuberculosis H37Rv complete genome entry in
the EMBL database [accession no. AL123456 (version 2)].
In silico tryptic digestions. The alternative protein sequences
generated above were subjected to an in silico tryptic digest using
the proteogest software from the University of Toronto (Cagney
et al., 2003) (downloaded from http://www.utoronto.ca/emililab/
proteogestcode.htm). This run was performed using the standard
tryptic digest settings (no missed cleavages, no modiﬁcation, no
cleavage where R or K are followed by P). The output of the proteo-
gest program is available as Supplementary Table S2.
Protein test set selection. In order to assess the feasibility of our
strategy, we decided to focus initially on the proteins most likely to
have their deﬁnitive translation start identiﬁed by MS. Thus, the
alternative protein sequences were screened according to a number
of technical criteria. First we discarded any protein not in a set of
289 proteins for which a 2D-gel spot had been identiﬁed in a pre-
vious large-scale proteomics analysis of M. tuberculosis (http://
web.mpiib-berlin.mpg.de/cgi-bin/pdbs/2d-page/extern/index.cgi). We
next eliminated any protein for which the predicted mass of the ﬁrst
N-terminal tryptic fragment of the p0 protein was not between 800
and 2000 Da (the best resolution range for our MS equipment), and
proteins without an arginine at the C-terminal end of the p0 tryptic
peptide [as ionization in MALDI-MS is less effective in lysine-con-
taining peptides than in arginine-containing ones (Krause et al.,
1999)]. The remaining 76 proteins were then ranked according to
the minimal number of alternative starts (i.e. least total number of
‘m’ and ‘p’ variants) and least number of fragments assuming a p0
start. This selection and classiﬁcation task was performed using the
ParseProteogest.pl program, which also calculates N-terminal tryptic
fragment weights, including possible modiﬁcations such as methio-
nine formylation and fragment acetylation. The output of the
ParseProteogest.pl program is available as Supplementary Table S3.
The data for M. tuberculosis protein GlpX (Rv1099c) were added to
the list, because although the protein does not meet all our selection
criteria, we had strong previous evidence of incorrect translational
start prediction for it (Movahedzadeh et al., 2004). From these
Fig. 1. General strategy for identifying alternative translation start positions and tryptic digest peptides: application to GlpX
(Rv1099c). The six alternative translation starts for GlpX are indicated by the labelled arrows. The minus (m)1, m2, m3 and m4
starts are located upstream of the original (p0) translation start indicated in the M. tuberculosis genome annotation. The plus
(p)1 and p2 starts are downstream of the original translation start prediction. The putative trypsin cleavage sites are indicated
by the ‘T’-labelled double-tailed bars. The resulting tryptic peptides are shown by the horizontal boxes. Tryptic fragments
identiﬁed by MS/MS are shown in white; those not detected are shown in black. The ﬁgure shows that the detected fragments
could only have resulted from the digest of the m2 variant. For reference, the M. tuberculosis sequence was aligned with the
N-terminal region of six other actinomycete GlpX homologues, as well as with the E. coli homologue. Asterisks indicate
perfectly conserved residues; colons indicate conserved substitutions (start codon methionines are ignored). The C.
glutamicum homologue TSS (at position ”14) has been conﬁrmed experimentally (Rittmann et al., 2003). Organisms are E.
coli (Eco), Streptomyces coelicolor (Sco), Corynebacterium diptheriae (Cdi), C. glutamicum (Cgl), Mycobacterium smegmatis
(Msm), Mycobacterium leprae (Mlp), Mycobacterium avium (Mav) and M. tuberculosis (Mtb).
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further investigation (Table 1). All these proteins were tested for the
presence of a signal peptide using the online SignalP 3.0 resource
available at http://www.cbs.dtu.dk/services/SignalP/ (Bendtsen et al.,
2004), and no signal peptide was detected in any of them.
2D gel electrophoresis (2-DE)/MALDI-MS and MS/MS.
Cellular proteins of M. tuberculosis H37Rv were prepared and
300 mg analysed by 2-DE, as previously described (Jungblut et al.,
1999). Protein spots on analytical gels were visualized by Coomassie
brilliant blue G250 staining (Doherty et al., 1998). Spots were
excised and digested in-gel (Lamer & Jungblut, 2001). MALDI-MS
was performed on a PerSeptive Voyager Elite time-of-ﬂight instru-
ment (PerSeptive), for which 0.5 ml peptide solution was mixed with
an equal amount of dehydroxybenzoic acid (DHB) matrix and
applied to a MALDI sample template. Mass spectra were recorded in
Table 1. MS analyses of N-terminal peptides from M. tuberculosis proteins
MetOx, oxidized methionine.
Gene
name
Rv no. Spot
no*
LocationD Mass of
N-terminal
peptide
Sequence of N-terminal peptided Prediction§ Comments
Rv0250c Rv0250c 5_19 CP 1781.93 (L)STTAELAELHDLVGGLR p0 fMet cleaved
Rv0313 Rv0313 5_18 CP 1733.68 (V)GDYGPFGFDPDEFDR p0 fMet cleaved
rpmC Rv0709 5_154 CP 984.544 (M)AVGVSPGELR p0 fMet cleaved
Rv0738 Rv0738 3_350 CP 1130.51
(2 MetOx)
[V]MoxDPLMoxAHQR|| p0 MS/MS conﬁrmed.
2MetOx detected; thus
fMet deformylated
but not cleaved. GTG
start codon
greA Rv1080c 5_65 CP 1816.74 (M)TDTQVTWLTQESHDR p0 fMet cleaved
glpX Rv1099c 1_249/1_216 CP 2408.1 (M) Ac-TAEGSGSSTAAVASHDPSH-
TRPSR
Ac-m2/m2 MS/MS conﬁrmed. fMet
cleaved. Both acetylated
and non-acetylated
forms found
Rv1109c Rv1109c 3_443# CP 834.62 (M)ATAPYGVR p0 fMet cleaved
ribH Rv1416 5_97 CP 1842.94
(MetOx)
[V]MoxKGGAGVPDLPSLDASGVR|| m1 MS/MS conﬁrmed. fMet
deformylated
but not cleaved. GTG
start codon
Rv1558 Rv1558 6_33 CP/CSN 1674.79 (M)PLSGEYAPSPLDWSR p0 fMet cleaved
argD Rv1655 1_386/2_17 CP 1155.52
(MetOx)
(M) Ac-TGASTTTATMoxR** Ac-p0/p0 fMet cleaved. Both
acetylated and
non-acetylated
forms found.
Internal Met
oxidized
prcA Rv2109c 3_325/3_372 CSN 1630.74
(MetOx)
(V) Ac-SFPYFISPEQAMoxRDD Ac-p0/p0 fMet cleaved
Rv2908c Rv2908c 6_19dd CP 1393.76 (M)SAVVVDAVEHLVR p0 fMet cleaved
Rv3143 Rv3143 5_149 CP 846.42 (V)PDSSTALR p0 fMet cleaved
*All from M. tuberculosis unless otherwise mentioned.
DCP, cellular protein; CSN, culture supernatant.
dParentheses indicate a missing residue, presumed to be a cleaved fMet, and the amino acid predicted from the DNA sequence.
§Identity of start peptide. p0 indicates that the annotation in the published genome sequence is correct. m1/m2 indicates that the ﬁrst or second
upstream start codon is used. ‘Ac’ indicates that the peptide is N-terminally acetylated.
||Brackets indicate the codon present where an uncleaved methionine was identiﬁed (M=ATG, V=GTG, L=TTG).
Non-acetylated peptide also found, mass 2366.1.
#Spot from Mycobacterium bovis BCG Chicago.
**Non-acetylated peptide also found, mass 1113.52.
DDNon-acetylated peptide also found, mass 1588.74.
ddSpot from M. tuberculosis Erdman.
http://mic.sgmjournals.org 523
Experimental determination of translational startsReﬂectron mode with delayed extraction ‘on’. Two hundred and
ﬁfty-six laser shots constituted one spectrum. Reanalysis for MS/MS
conﬁrmation of the N termini was performed with a 4700
Proteomics Analyser (Applied Biosystems).
For the digestion of spots, the gel pieces were destained in 500 ml
destaining buffer [200 mM NH4HCO3, 50% acetonitrile (ACN)],
equilibrated in 500 ml digestion buffer (50 mM NH4HCO3, 5% ACN).
The supernatant was removed and the gel piece was dried within
30 min in a Microconcentrator 5301 (Eppendorf) at 30uC, and then
digested in 25 ml digestion buffer containing 0.1 mg trypsin (sequen-
cing-grade modiﬁed trypsin, Promega). After digestion overnight at
37uC, the reaction tube was centrifuged and the supernatant (S1)
transferred into another tube. To the gel piece, 25 ml 60% ACN, 0.3%
triﬂuoroaceticacid(TFA)wasaddedtostopthetrypsinreactionandto
shrink and wash the gel piece. After 10 min the supernatant (S2) was
added to S1. The gel piece was washed and shrunk with 25 ml 100%
ACN. This supernatant was then added to S1+S2 and dried in the
Microconcentrator 5301 at 65uC. For the MS analysis, the dried
peptides were dissolved in 1 ml 33% ACN and 0.1% TFA, and 0.25 ml
ofthissolutionwasmixedwith0.5 mlalpha-cyano-4-hydroxycinnamic
acid(CHCA)solubilized in50%ACN,0.3%TFAonParaﬁlm,andthe
resulting mixture was transferred to the template of the mass
spectrometer and analysed.
The peptide masses were obtained using the following parameters:
reﬂectronmode,20 kVaccelerating voltage,alowmassgateof500 Da,
and a mass range between 500 and 4000 Da. MS/MS spectra were
obtained with and without collision gas. The database searches were
performed with Mascot (http://www.matrixscience.com). Search
parameters were: 30 p.p.m. peptide mass tolerance for peptide mass
ﬁngerprints, and 0.3 Da for MS/MS spectra. MS/MS data were
compared with the theoretical sequence data of the protein under
investigation. Search criteria were: one and two missed cleavages
allowed and possible oxidation of methionine; N-terminal acetylation
of the protein; and pyroglutamic acid formation from N-terminal
glutamine, propionamide and sodium adducts. MS/MS spectra were
manually evaluated.
The MS/MS peaklists can be found within the 2D-PAGE database
(http://www.mpiib-berlin.mpg.de/2D-PAGE/), linked to the relevant
protein.
RESULTS
Conﬁrming the M. tuberculosis GlpX start
Our approach arose from an earlier set of experiments in
whichwepredictedthattheannotatedtranslationalstartsfor
two M. tuberculosis proteins were incorrect (Movahedzadeh
et al., 2004). This is despite the fact that this was one of the
earliest completed genome sequences in which each ORF
was manually annotated (Cole et al., 1998), and which has
since been rigorously reannotated (Camus et al., 2002).
Our predicted reassignment of the start of GlpX (Rv1099c)
was based mainly on extensive comparative genomic
analysis (Movahedzadeh et al., 2004). We observed that
amino acid homology extended beyond the annotated start,
andweproposedthattranslationactuallystarted34residues
earlier (Fig. 1). Crucially, some experimental N-terminal
sequence data had been reported for the Corynebacterium
glutamicum GlpX orthologue, Fbp (Rittmann et al., 2003),
which allowed us to be more conﬁdent about our new
prediction for the M. tuberculosis GlpX. The extension of
GlpX led to a conﬂict with the adjacent and divergently
transcribed gene Rv1100, and we proposed an alternative
start for this as well. This apparent misannotation therefore
completely altered the predicted shared promoter region for
two genes.
AsGlpXhadbeenidentiﬁedproteomicallyinM.tuberculosis
extracts (http://web.mpiib-berlin.mpg.de/cgi-bin/pdbs/2d-
page/extern/index.cgi), we reasoned that existing MS data
might be able to conﬁrm or refute our reannotation. We
therefore predicted peptide masses that would distinguish
the predictions (Fig. 1, Table 1). Analysis of the existing
data was inconclusive, but generation of new MS data
conﬁrmed (a) the presence of a peptide (NLAMELVR) that
crossed the originally predicted start site and (b) the
presence of a peptide that corresponded to our new
prediction (Fig. 2). No peak corresponding to the original
start prediction was seen.
The start peptide that we identiﬁed (TAEGSGSSTA-
AVASHDPSHTRPSR) lacked an N-terminal formyl-
methionine (fMet), which is not an unusual ﬁnding (see
Discussion). Interestingly, GlpX occurred in two spots on
the 2D gel; the more acidic one showed a shift of 42 in mass
for this peptide, suggesting an acetylation (Fig. 2). MS/MS
spectra resulted in y ions up to y21 without this shift,
suggesting acetylation of the N-terminal threonine. We
concluded that the start of the new prediction was correct,
with posttranslational modiﬁcations to cleave fMet and
partially acetylate the N terminus.
Developing a higher-throughput approach
The success with GlpX showed the potential of peptide mass
mapping to experimentally verify protein starts on a large
scale.Wethereforecalculatedthemassesofstartpeptidesfor
all predicted proteins in the M. tuberculosis genome. We
called the currently annotated start codon ‘p0’, and
identiﬁcation of tryptic peptides starting at this codon
would support the current annotation.
We then identiﬁed potential alternative start codons
upstream (m1, m2, etc. for ‘minus’) and downstream (p1,
p2, etc. for ‘plus’) (see Fig. 1); for each of these we
recalculated thepredicted masses of start peptides. Use of an
upstream start codon would result in a longer protein, with
the p0 codon-encoded residue contained within another
peptide, the identiﬁcation of which would be evidence
against p0 (as occurred with GlpX). We therefore also
calculated the masses of such trans-p0 peptides. The
algorithm used is described in Methods, and shown in
Fig. 1.
To test our approach more rigorously, a shortlist of 15
proteinswasdrawnup.Thiswasbasedon(a)thepresenceof
existing MS data, (b) no obvious signal sequence being
present, (c) the mass of the p0 peptide falling within the
range of ideal sensitivity for MS, and (d) the peptide being
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residues (see Methods).
Table 1 shows the data that we obtained. We initially
analysed existing data, which were adequate in some
instances but not in others, requiring repeat MALDI-MS
analyses. Of the 15 proteins, we had difﬁculties with two. In
one case (Rv1017c; PrsA), the predicted N-terminal peptide
coincided with a common contamination peak. Another
(Rv2557) came from a spot containing more than one
protein and was therefore unusable for the present
investigation. The other 13 proteins were successfully
analysed, and are brieﬂy presented below.
Peptide start analyses
Conﬁrmed starts. We conﬁrmed the starts for 11 pro-
teins (see Table 1). In most cases, a peptide lacking fMet
was detected, although in one case (Rv0738), deformy-
lated methionine was present. In two cases (ArgD and
PrcA), both N-terminally acetylated peptides were found
in addition to the non-acetylated form.
Revised starts
GlpX (Rv1099c): m2. As described above, our hypoth-
esis that GlpX is 34 aa residues larger than originally pre-
dicted was conﬁrmed (Fig. 1). The fMet is cleaved and, in
addition to an unmodiﬁed protein species, there is also a
less-abundant spot with an acetylated N-terminal peptide
(Fig. 2).
RibH (Rv1416): m1. The ribH gene lies downstream of
ribA2 in what appears to be an operon (Fig. 3). There is a
14 bp gap between the stop codon of ribA2 and the pre-
dicted start valine of ribH. No peak corresponding to this
start was seen; instead, there was a clear peak correspond-
ing to the peptide crossing the originally predicted start.
The m1 start lies 2 aa upstream of the peptide identiﬁed,
and as the second residue is a lysine, should be cleaved in
the procedure used. We identiﬁed both the predicted
cleaved peptide (GGA...) and a peptide in which the tryp-
sin had not cleaved (MKGGA...). Where there are alterna-
tive start codons (GTG, TTG), fMet is inserted rather
than the usual amino acid that these would code for
Fig. 2. MS of GlpX. (a) SDS-PAGE indicating two forms of GlpX, acetylated (1) and non-acetylated (2). (b) Identiﬁcation of a
peptide spanning the annotated start (NLAMELVR=945.52; MS/MS-detected b ions: b2, b3, b4, b5, b6; detected y ions: y1, y2,
y3, y5. (c) Identiﬁcation of an acetylated N-terminal peptide (Ac-TAEGSGSSTAAVASHDPSHTRPSR=2408.1; MS/MS: y4, y5,
y8, y9, y10, y21). (d) Identiﬁcation of a non-acetylated N-terminal peptide (TAEGSGSSTAAVASHDPSHTRPSR=2366.1; MS/
MS: y1, y4, y8, y9, y21).
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Experimental determination of translational starts(Laursen et al., 2005). The ﬁnding therefore of a methio-
nine encoded by a GTG, which would normally code for
valine, is in itself proof that this is the translational start.
This sequence was conﬁrmed by MS/MS. The peptide
starting with GGA was conﬁrmed by eight y ions (1, 2, 3,
5, 6, 9, 10, 12) and three b ions (4, 5, 8) and the peptide
starting with MKGGA by eight y ions (1, 3, 4, 5, 6, 9, 10,
12). The expected ions y5 and y10, both with a cleavage
after D and a mass loss of 64, further conﬁrmed the
sequence. This new ribH start would overlap with the
ribA2 stop codon (GTGA; Fig. 3) at position 24. Such an
arrangement is known to be the most common for pro-
karyotic genes thought to be part of the same operon
(Salgado et al., 2000), as is the case with ribA2 and ribH.
DISCUSSION
We have shown that proteomic methods can be used to
identify protein TSSs. Of 15 proteins tested, we conﬁrmed
predicted starts for 11, and reassigned the starts of two. In
one case (glpX; Rv1099c), the reassigned start affects the
adjacent gene and completely alters the predicted promoter
regionfor both genes. In the second case (ribH; Rv1416),the
alterationisminor,butmakesbiologicalsense,andindicates
that a predicted ribosome-binding site is probably non-
functional. As the glpX case was preselected, one of 12
randomly chosen proteins was misassigned. The sample is
small, but indicates that a large number of proteins may be
incorrectly annotated. While the correction of misassigned
starts underlines the need to carry out this work,
conﬁrmation of current predictions is also an important
contribution. As proteins are mainly identiﬁed through
homology, it is critical that at least a small number of
representatives have conﬁrmed TSSs, in order to anchor the
remaining predictions within an experimental context.
Our approach is simple in concept, and has the great
advantage that most of the data are routinely generated
during standard proteomic procedures. TSS identiﬁcation
has previously been a relatively neglected area; in the past,
N-terminal sequencing was the main method for protein
identiﬁcation, but this has been largely supplanted by more
sensitive MALDI-MS technology. There have been large-
scaleN-terminalsequencingprojects;forexample,Linketal.
(1997)studiedtheNterminiof295E.coliproteins.Ofthese,
72 failed because of signal peptide cleavage or N-terminal
blockage. Of 223 N-terminal starts characterized, 10 (4.5%)
were reassigned. However, they used Edman degradation,
and the need to use different chemistries makes this less
practicalasaroutinemethod.Wesuggestthatapplicationof
themethoddescribedhereinproteomicslaboratorieswould
dramatically increase the number of experimentally deter-
mined protein TSSs, with minimal extra resources. There is
also the possibility of retrospective examination using pre-
existing MS datasets, although we preferred to carry out
conﬁrmatory analyses. This emphasizes the importance of
storing MS data in proteome databases.
It would be possible to identify some of the predicted N-
terminal peptides using a standard Mascot search, and the
fact that this does not happen, or that the data do not feed
into the wider community, may reﬂect different priorities
(proteinidentiﬁcationbeingthenormalaim).However,our
method goes further, and evidence for a start peptide is
supported (a) by the absence of alternatives and (b) by the
search for peptides spanning potential starts. We accept that
as with all peptide mass mapping, while the identiﬁcation of
a single peak with a particular molecular mass provides
supporting evidence for the presence of a particular peptide,
additional MS/MS analysis to conﬁrm peptide identity is
required to be conﬁdent about the assignment.
More recent large-scale proteome projects have used
proteomics to help genome annotation (Jaffe et al., 2004;
Lipton et al., 2002). In a reanalysis of the Mycoplasma
pneumoniae genome, over 81% of the predicted ORFs were
identiﬁed proteomically, and 16 new ORFs were detected.
The algorithm used resulted in the extension of the
predicted N termini of 19 proteins, on the basis that
peptideswereidentiﬁedthatextendedbeyondtheannotated
start. The translational start was then reassigned by looking
upstream for a start codon. However, these groups did not
actually identify start peptides.
We looked for proteins starting at ATG, GTG or TTG
codons.ATGistheclassical initiation codon,butinGC-rich
genomes such as that of M. tuberculosis, GTG is extremely
common. Our method conclusively conﬁrms the starts in
which a methionine residue is seen with a GTG or TTG
codon, as this is the only scenario in which such a
substitution would take place. Thus, methionine residues
Fig. 3. TSS reassignment for ribH
(Rv1416). There is a 14 bp gap between
the stop codon of ribA2 and the M. tuber-
culosis annotation predicted start codon
(p0) of ribH. No peak corresponding to this
start was seen; however, peaks correspond-
ing to the m1 start variant (dashed box)
were identiﬁed. Thus, the corrected TSS
overlaps the upstream ribA2 (Rv1415) gene
by 4 bp, an arrangement often observed in
prokaryotic genomes for functionally related
genes in a common operon.
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start with GTG (valine) codons.
There are limitations to our method. TSSs of proteins that
are cleaved (for example removal of signal sequences) will
not be resolved. However, it would be possible to adapt our
method to identify such cleaved N termini, as signal
sequence cleavage sites can be predicted. We deliberately
chose a subset of proteins that would maximize the chance
of success, suggesting that our success rate (84%) would be
less likely with a random set of proteins. One criterion we
used was to choose proteins for which the predicted N-
terminal peptide was readily resolvable using our experi-
mental conditions and mass spectrometer. If a protein had
anN-terminalpeptide that wasnotsuitable, thenalternative
proteases could be used, or an orthologue in another species
might be more amenable. Also, the presence or absence of a
peptide that crosses the predicted start might be detectable,
even if the start peptide itself was not. We encountered
another problem with Rv2908c, in which a predicted start
(p2)corresponded toatrypticpeptide(becauseitlaynextto
an arginine or lysine residue); in such cases it would be
necessary to include additional evidence before conﬁdently
assigning this as a start. Finally, our approach is directly
applicable to all prokaryote genomes, but will need adapting
for eukaryotes, in which exons need to be considered.
The applied method described here can use data from 2-DE/
MS and LC/MS identiﬁcations. 2-DE/MS data have the
advantage of high sequence coverage and therefore have a
better chance to have access to the N terminus. The mass
analysis of a 2-DE spot with peptide mass ﬁngerprinting
investigates only one protein, because 2-DE separates
proteins. Therefore, the N-terminal peptide can be searched
in a relatively small dataset of the proteolytically obtained
peptides of this single protein. There is also access to MS
and MS/MS data in already existing proteome databases
(e.g. http://www.mpiib-berlin.mpg.de/2D-PAGE/). LC/MS
methods have an advantage for sensitive identiﬁcation of
proteins, because only two or three peptides are sufﬁcient
for identiﬁcation. This advantage turns into a limitation for
the problem of the identiﬁcation of posttranslational
modiﬁcations and N termini (Schmidt et al., 2004), because
the probability that the N terminus or the modiﬁcation is
within the two or three identiﬁed peptides is very low.
Nevertheless, our strategy for N-terminus conﬁrmation or
correction has the potential to be applied to the LC/MS
approach by changing the experimental design to focus on
the N-terminal peptide, as for example by the Cofradic
approach (Gevaert et al., 2003).
Both of the misannotated proteins that we identiﬁed were
longer than the predicted proteins. Although our sample
wassmall,wemightexpectthistobethecasewithacarefully
annotated genome, as alignments to other homologues will
tend to give a conservative indication of length. With
genomes for which gene start assignment uses other
assumptions, the balance of ‘m’ and ‘p’ reassignments
might change.
One beneﬁt of proteomic analyses is the ability to identify
posttranslational modiﬁcations. A common modiﬁcation is
removal of fMet, and we observed this for 11 of the 13
proteins.Inthetwocasesinwhichtherewasnocleavage,the
residue had been deformylated. In some cases, methionine
residues (both N-terminal and internal) had been oxidized
(Schmidt et al., 2006); we cannot tell if this occurred
intracellularly or during the experimental procedure. Most
interestingly, N-terminal peptides from three proteins
(GlpX, ArgD and PrcA) were at least partially acetylated.
MS/MS sequencing showed the acetyl group to be on the N-
terminal residue; although N-terminal acetylation is the
norm in eukaryotic proteins, it is reported to be rare in
prokaryotes (Polevoda & Sherman, 2002). It is amino acid
dependent (Persson et al., 1985), and our observations of
acetylated serine or threonine residues are in line with
previous work. N-terminal acetylation may not always alter
function, but in some cases it does; thus, the important M.
tuberculosis antigen ESAT-6, which normally interacts with
the protein CFP-10, fails to do so when acetylated (Okkels
et al., 2004). We show here that three out of 13 proteins
(23%) have an acetylated form. This raises the question of
whether the assumption that few prokaryotic proteins are
acetylatedistrueforallbacteria.Muchoftheexistingdogma
has come from the analysis of E. coli proteins, of which in a
survey of 810 proteins (Polevoda & Sherman, 2003), only
threewereacetylated,allthreebeingribosomalsubunits(S5,
S18 and L12); our data suggest that the mycobacteria, at
least, may be very different. A larger survey of proteins from
these and other bacteria is needed to conﬁrm this.
In this paper we suggest a simple strategy for the
experimental identiﬁcation of TSSs. The correct identiﬁca-
tion of these sites affects not only the length and possibly the
function of the encoded proteins, but also key regulatory
factors, such as the presence or absence of upstream
regulatory sequences and the identiﬁcation of genes likely to
be co-expressed as part of an operon. We believe that the
proposed nomenclature used herein for describing alter-
native start sites could be a useful standard for TSS
identiﬁcation in genome annotation. Since the data are
often available and the strategy is therefore not particularly
onerous in time or materials, we would recommend that
researchers working on a particular gene attempt to mine
proteomics databases for TSS identiﬁcation, and that
researchers performing large-scale proteomics investiga-
tions consider making TSS identiﬁcation part of their
protein-characterization procedure. The experimental iden-
tiﬁcation of the TSS of a protein should be of use in
annotating orthologues in other species, so that work in
different laboratories would support a general effort to
improve ORF annotation.
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